表紙
市場調查報告書

全球乾癬性關節炎治療藥市場:產業分析,規模,佔有率,成長,趨勢,預測

Arthritis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版商 Transparency Market Research 商品編碼 823511
出版日期 內容資訊 英文 224 Pages
商品交期: 最快1-2個工作天內
價格
全球乾癬性關節炎治療藥市場:產業分析,規模,佔有率,成長,趨勢,預測 Arthritis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日期: 2019年10月18日內容資訊: 英文 224 Pages
簡介

本報告提供全球乾癬性關節炎治療藥市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介等相關資訊。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場趨勢

  • 簡介
  • 概要
  • 市場概要
    • 促進要素
    • 阻礙要素
    • 機會
  • 市場分析與預測

第5章 市場預測

  • 開發平台分析
  • 合併·收購
  • 疾病罹患率與發病率

第6章 各類藥物市場分析與預測

  • 簡介和定義
  • 調查結果/趨勢
  • 市場值預測
    • TNF抑制劑
    • 白細胞介素抑制劑
    • PDR4抑制劑
    • 其他
  • 市場魅力度

第7章 各給藥途徑市場分析與預測

  • 簡介和定義
  • 調查結果/趨勢
  • 市場值預測
    • 口服
    • 非口服
    • 局部
  • 市場魅力度

第8章 各流通管道市場分析與預測

  • 簡介和定義
  • 調查結果/趨勢
  • 市場值預測
    • 院內藥局
    • 零售藥局
    • 線上藥局
  • 市場魅力度

第9章 各地區市場分析與預測

  • 調查結果
  • 市場值佔有率分析
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力度

第10章 北美市場

第11章 歐洲市場

第12章 亞太地區市場

第13章 南美市場

第14章 中東·非洲市場

第15章 競爭環境

  • 競爭矩陣
  • 市場佔有率分析
  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Arthritis Therapeutics Market - Scope of the Report

TMR'S report on the global arthritis therapeutics market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global arthritis therapeutics market for the period of 2017-2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global arthritis therapeutics market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global arthritis therapeutics market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approach to study the various phenomena in the global arthritis therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global arthritis therapeutics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global arthritis therapeutics market. The next section of the global arthritis therapeutics market report highlights key insights, which include the growing prevalence of rheumatoid arthritis, osteoarthritis, psoriatic arthritis and other types, ongoing clinical trials and pipeline analysis, major arthritis brands in the market, and regulatory scenarios in the global arthritis therapeutics market.

The report delves into the competitive landscape of the global arthritis therapeutics market. Key players operating in the global arthritis therapeutics market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOTs are some of the attributes of players in the global arthritis therapeutics market profiled in this report.

Key Questions Answered in the Arthritis Therapeutics Market Report

How does the recent launching of novel and effective drugs provide scope of growth in the global arthritis therapeutics market?

How are ongoing clinical trials for arthritis widening the scope for arthritis therapeutics?

How are various drug classes effective in the treatment of arthritis, and provide opportunities to key players for growth?

What are the revenue share projections of key segments under various criteria in the global arthritis therapeutics market for the forecast period?

Which segment is likely to lead the arthritis therapeutics market in terms of revenue by 2027?

How are changing regulatory scenarios, along with changing healthcare systems in developed and developing countries having an impact on the overall arthritis therapeutics market?

Arthritis Therapeutics Market - Research Objectives and Research Approach

The comprehensive report on the global arthritis therapeutics market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, and healthcare compliances laid down by accredited agencies in the purview of research in the global arthritis therapeutics market. It is followed by market introduction, market dynamics, and an overview of the global arthritis therapeutics market, which includes TMR analysis of the market drivers, restraints, and trends affecting the growth of the global arthritis therapeutics market. Furthermore, to understand the Y-o-Y trends of the arthritis therapeutics market, a Y-o-Y analysis with elaborated insights on the same have been provided. The next section of the global arthritis therapeutics report highlights key insights, which include growing prevalence of arthritis disease across the globe, top analysis of key brands, pipeline analysis, and key industry developments in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of the actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period. To ascertain the size of the global arthritis therapeutics market in terms of value, revenue generated by key arthritis drugs manufacturers has been mapped. The forecast presented here assesses the total revenue generated in the arthritis therapeutics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Arthritis Therapeutics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Market Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Arthritis Therapeutics Market Analysis and Forecast, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key product/brand Analysis
  • 5.2. Pipeline Analysis
  • 5.3. Disease Prevalence & Incidence Rate globally with key countries
  • 5.4. Regulatory Scenario by Region/globally

6. Global Arthritis Therapeutics Market Analysis and Forecast, By Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 6.3.1. Rheumatoid Arthritis
    • 6.3.2. Osteoarthritis
    • 6.3.3. Psoriatic Arthritis
    • 6.3.4. Gout
    • 6.3.5. Others
  • 6.4. Market Attractiveness By Type

7. Global Arthritis Therapeutics Market Analysis and Forecast, By Drug Class

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
    • 7.3.1. TNF Inhibitors
    • 7.3.2. Interleukin Inhibitors
    • 7.3.3. NSAIDs
    • 7.3.4. Corticosteroids
    • 7.3.5. Xanthine Oxidase Inhibitors
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Drug Class

8. Global Arthritis Therapeutics Market Analysis and Forecast, By Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Topical
  • 8.4. Market Attractiveness By Route of Administration

9. Global Arthritis Therapeutics Market Analysis and Forecast, By Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness By Distribution Channel

10. Global Arthritis Therapeutics Market Analysis and Forecast, By Region

  • 10.1. Key Findings
  • 10.2. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Sub-region /Region

11. North America Arthritis Therapeutics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 11.2.1. Rheumatoid Arthritis
    • 11.2.2. Osteoarthritis
    • 11.2.3. Psoriatic Arthritis
    • 11.2.4. Gout
    • 11.2.5. Others
  • 11.3. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
    • 11.3.1. TNF Inhibitors
    • 11.3.2. Interleukin Inhibitors
    • 11.3.3. NSAIDs
    • 11.3.4. Corticosteroids
    • 11.3.5. Xanthine Oxidase Inhibitors
    • 11.3.6. Others
  • 11.4. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
    • 11.4.1. Oral
    • 11.4.2. Parenteral
    • 11.4.3. Topical
  • 11.5. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. North America Market Attractiveness Analysis
    • 11.7.1. By Type
    • 11.7.2. By Drug Class
    • 11.7.3. By Route of Administration
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country/Sub-region

12. Europe Arthritis Therapeutics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 12.2.1. Rheumatoid Arthritis
    • 12.2.2. Osteoarthritis
    • 12.2.3. Psoriatic Arthritis
    • 12.2.4. Gout
    • 12.2.5. Others
  • 12.3. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
    • 12.3.1. TNF Inhibitors
    • 12.3.2. Interleukin Inhibitors
    • 12.3.3. NSAIDs
    • 12.3.4. Corticosteroids
    • 12.3.5. Xanthine Oxidase Inhibitors
    • 12.3.6. Others
  • 12.4. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
    • 12.4.1. Oral
    • 12.4.2. Parenteral
    • 12.4.3. Topical
  • 12.5. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Europe Market Attractiveness Analysis
    • 12.7.1. By Type
    • 12.7.2. By Drug Class
    • 12.7.3. By Route of Administration
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Arthritis Therapeutics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 13.2.1. Rheumatoid Arthritis
    • 13.2.2. Osteoarthritis
    • 13.2.3. Psoriatic Arthritis
    • 13.2.4. Gout
    • 13.2.5. Others
  • 13.3. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
    • 13.3.1. TNF Inhibitors
    • 13.3.2. Interleukin Inhibitors
    • 13.3.3. NSAIDs
    • 13.3.4. Corticosteroids
    • 13.3.5. Xanthine Oxidase Inhibitors
    • 13.3.6. Others
  • 13.4. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
    • 13.4.1. Oral
    • 13.4.2. Parenteral
    • 13.4.3. Topical
  • 13.5. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region /Sub-region, 2017-2027
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Asia Pacific Market Attractiveness Analysis
    • 13.7.1. By Type
    • 13.7.2. By Drug Class
    • 13.7.3. By Route of Administration
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America Arthritis Therapeutics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 14.2.1. Rheumatoid Arthritis
    • 14.2.2. Osteoarthritis
    • 14.2.3. Psoriatic Arthritis
    • 14.2.4. Gout
    • 14.2.5. Others
  • 14.3. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
    • 14.3.1. TNF Inhibitors
    • 14.3.2. Interleukin Inhibitors
    • 14.3.3. NSAIDs
    • 14.3.4. Corticosteroids
    • 14.3.5. Xanthine Oxidase Inhibitors
    • 14.3.6. Others
  • 14.4. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
    • 14.4.1. Oral
    • 14.4.2. Parenteral
    • 14.4.3. Topical
  • 14.5. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region /Sub-region, 2017-2027
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Latin America Market Attractiveness Analysis
    • 14.7.1. By Type
    • 14.7.2. By Drug Class
    • 14.7.3. By Route of Administration
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Arthritis Therapeutics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017-2027
    • 15.2.1. Rheumatoid Arthritis
    • 15.2.2. Osteoarthritis
    • 15.2.3. Psoriatic Arthritis
    • 15.2.4. Gout
    • 15.2.5. Others
  • 15.3. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
    • 15.3.1. TNF Inhibitors
    • 15.3.2. Interleukin Inhibitors
    • 15.3.3. NSAIDs
    • 15.3.4. Corticosteroids
    • 15.3.5. Xanthine Oxidase Inhibitors
    • 15.3.6. Others
  • 15.4. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
    • 15.4.1. Oral
    • 15.4.2. Parenteral
    • 15.4.3. Topical
  • 15.5. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region , 2017-2027
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Middle East & Africa Market Attractiveness Analysis
    • 15.7.1. By Type
    • 15.7.2. By Drug Class
    • 15.7.3. By Route of Administration
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Share Analysis By Company (2018)
  • 16.2. Company Profiles
    • 16.2.1. Novartis AG
      • 16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.1.2. Financial Overview
      • 16.2.1.3. Product Portfolio
      • 16.2.1.4. Strategic Overview
      • 16.2.1.5. SWOT Analysis
    • 16.2.2. Eli Lilly and Company
      • 16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.2.2. Financial Overview
      • 16.2.2.3. Product Portfolio
      • 16.2.2.4. Strategic Overview
      • 16.2.2.5. SWOT Analysis
    • 16.2.3. Amgen, Inc.
      • 16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.3.2. Financial Overview
      • 16.2.3.3. Product Portfolio
      • 16.2.3.4. Strategic Overview
      • 16.2.3.5. SWOT Analysis
    • 16.2.4. Merck & Co., Inc.
      • 16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.4.2. Financial Overview
      • 16.2.4.3. Product Portfolio
      • 16.2.4.4. Strategic Overview
      • 16.2.4.5. SWOT Analysis
    • 16.2.5. Bristol-Myers Squibb Company
      • 16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.5.2. Financial Overview
      • 16.2.5.3. Product Portfolio
      • 16.2.5.4. Strategic Overview
      • 16.2.5.5. SWOT Analysis
    • 16.2.6. Pfizer, Inc.
      • 16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.6.2. Financial Overview
      • 16.2.6.3. Product Portfolio
      • 16.2.6.4. Strategic Overview
      • 16.2.6.5. SWOT Analysis
    • 16.2.7. AbbVie, Inc.
      • 16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.7.2. Financial Overview
      • 16.2.7.3. Product Portfolio
      • 16.2.7.4. Strategic Overview
      • 16.2.7.5. SWOT Analysis
    • 16.2.8. Janssen Global Services, LLC (Johnson & Johnson)
      • 16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.8.2. Financial Overview
      • 16.2.8.3. Product Portfolio
      • 16.2.8.4. Strategic Overview
      • 16.2.8.5. SWOT Analysis
    • 16.2.9. F. Hoffmann-La Roche Ltd
      • 16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.9.2. Financial Overview
      • 16.2.9.3. Product Portfolio
      • 16.2.9.4. Strategic Overview
      • 16.2.9.5. SWOT Analysis
    • 16.2.10. Sanofi
      • 16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.10.2. Financial Overview
      • 16.2.10.3. Product Portfolio
      • 16.2.10.4. Strategic Overview
      • 16.2.10.5. SWOT Analysis

List of Tables

  • Table 01: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 02: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 03: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 04: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 05: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 06: North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 07: North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 08: North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration,
  • Table 09: North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 10: North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region , 2017-2027
  • Table 11: Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 12: Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 13: Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 14: Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 15: Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017-2027
  • Table 16: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 17: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 18: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 19: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 20: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017-2027
  • Table 21: Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 22: Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 23: Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 24: Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 25: Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017-2027
  • Table 26: Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 27: Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 28: Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 29: Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 30: Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017-2027

List of Figures

  • Figure 01: Global Arthritis Therapeutics Market Snapshot
  • Figure 02: Global Arthritis Therapeutics Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
  • Figure 03: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, 2017?2027
  • Figure 04: Global Arthritis Therapeutics Market Value Share (%), by Type (2018)
  • Figure 05: Global Arthritis Therapeutics Market Value Share (%), by Route of Administration (2018)
  • Figure 06: Global Arthritis Therapeutics Market Value Share (%), by Drug Class (2018)
  • Figure 07: Global Arthritis Therapeutics Market Value Share (%), by Distribution Channel (2018)
  • Figure 08: Global Arthritis Therapeutics Market Value Share (%), by Region (2018)
  • Figure 09: Global Arthritis Therapeutics Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 10: Global Arthritis Therapeutics Market Attractiveness, by Type, 2019-2027
  • Figure 11: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Rheumatoid Arthritis, 2017-2027
  • Figure 12: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Osteoarthritis, 2017-2027
  • Figure 13: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Psoriatic Arthritis, 2017-2027
  • Figure 14: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gout, 2017-2027
  • Figure 15: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2027
  • Figure 16: Global Arthritis Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 17: Global Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019-2027
  • Figure 18: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by TNF Inhibitors, 2017-2027
  • Figure 19: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Interleukin Inhibitors, 2017-2027
  • Figure 20: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NSAIDs, 2017-2027
  • Figure 21: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017-2027
  • Figure 22: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Xanthine Oxidase Inhibitors, 2017-2027
  • Figure 23: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2027
  • Figure 24: Global Arthritis Therapeutics Market Value Share(%), by Route of Administration, 2018 and 2027
  • Figure 25: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2017-2027
  • Figure 26: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Parenteral, 2017-2027
  • Figure 27: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2017-2027
  • Figure 28: Global Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019-2027
  • Figure 29: Global Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 30: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017-2027
  • Figure 31: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017-2027
  • Figure 32: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2017-2027
  • Figure 33: Global Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 34: Global Arthritis Therapeutics Market Value Share Analysis, by Region 2018 and 2027
  • Figure 35: Global Arthritis Therapeutics Market Attractiveness, by Region, 2019-2027
  • Figure 36: North America Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 37: North America Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027
  • Figure 38: North America Arthritis Therapeutics Market Attractiveness, by Type, 2019-2027
  • Figure 39: North America Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 40: North America Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019-2027
  • Figure 41: North America Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027
  • Figure 42: North America Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019-2027
  • Figure 43: North America Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 44: North America Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 45 : North America Arthritis Therapeutics Market Value Share (%), By Country/Sub-region , 2018 and 2027
  • Figure 46: North America Arthritis Therapeutics Market Attractiveness, By Country/Sub-region , 2019-2027
  • Figure 47: Europe Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 48: Europe Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027
  • Figure 49: Europe Arthritis Therapeutics Market Attractiveness, by Type, 2019-2027
  • Figure 50: Europe Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 51: Europe Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019-2027
  • Figure 52: Europe Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027
  • Figure 53: Europe Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019-2027
  • Figure 54: Europe Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 55: Europe Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 56: Europe Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027
  • Figure 57: Europe Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019-2027
  • Figure 58: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 59: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027
  • Figure 60: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Type, 2019-2027
  • Figure 61: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 62: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019-2027
  • Figure 63: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027
  • Figure 64: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019-2027
  • Figure 65: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 66: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 67 : Asia Pacific Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027
  • Figure 68: Asia Pacific Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019-2027
  • Figure 69: Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 70: Latin America Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027
  • Figure 71: Latin America Arthritis Therapeutics Market Attractiveness, by Type, 2019-2027
  • Figure 72: Latin America Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 73: Latin America Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019-2027
  • Figure 74: Latin America Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027
  • Figure 75: Latin America Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019-2027
  • Figure 76: Latin America Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 77: Latin America Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 78 : Latin America Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027
  • Figure 79: Latin America Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019-2027
  • Figure 80: Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 81: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027
  • Figure 82: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Type, 2019-2027
  • Figure 83: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027
  • Figure 84: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019-2027
  • Figure 85: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027
  • Figure 86: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019-2027
  • Figure 87: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 88: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 89: Middle East & Africa Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027